Skip to content
Twitter page opens in new window
Linkedin page opens in new window
Instagram page opens in new window
info@pharmaust.com
+61 8 9202 6814
PharmAust (PAA)
HOME
ABOUT
Company Overview
Management Team
Board
Corporate Directory
PIPELINE & TRIALS
Therapeutic Pipeline
MPL and Veterinary Trials
Clinical Trials – Dogs Wanted
MPL and Human Trials
Publications
Pet Cancer Information Service
INVESTOR CENTRE
News & Announcements
Company Research
Financial Reports
Annual Reports
Investor Presentations
Corporate Governance
Top 20 Shareholders
MEDIA
Dr. Richard Mollard – 6IX Interview March 2020
PharmAust In the News
PharmAust Videos
PharmAust New Cancer Treatment
PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
PharmAust on Youtube
CONTACT
HOME
ABOUT
Company Overview
Management Team
Board
Corporate Directory
PIPELINE & TRIALS
Therapeutic Pipeline
MPL and Veterinary Trials
Clinical Trials – Dogs Wanted
MPL and Human Trials
Publications
Pet Cancer Information Service
INVESTOR CENTRE
News & Announcements
Company Research
Financial Reports
Annual Reports
Investor Presentations
Corporate Governance
Top 20 Shareholders
MEDIA
Dr. Richard Mollard – 6IX Interview March 2020
PharmAust In the News
PharmAust Videos
PharmAust New Cancer Treatment
PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
PharmAust on Youtube
CONTACT
Appendix 3B: New issue announcement, application for quotation of additional securities and agreement
180316_Appendix 3B and 3Y Notice
Go to Top
